PharmaVoice

JULY 20, 2022

A look at how the COVID-19 pandemic exacerbated one of the world’s greatest public health concerns.

246

246

Pharmacy Times

JULY 20, 2022

What we're seeing as a trend is this significant increase in synthetic opioids, specifically fentanyl, being contaminated and causing severe overdoses.

149

149

PharmExec

JULY 20, 2022

Thursday, July 21st 2022 at 11am EST, 8am PST, 5pm CEST Join this webinar to hear industry thought leaders discuss how data and experiences serve clinical and commercial needs, explore which platforms and technologies can enable a robust digital health ecosystem, and share recommendations for building a digital health strategy fit for your business.

139

139

Pharmacy Times

JULY 20, 2022

Companies that incorporate Diversity, Equity, and Inclusion (DEI) into their everyday operations will be instrumental in shaping a new standard in their workforce and ultimately in society.

139

139

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmaceutical Technology

JULY 20, 2022

A key factor of Pfizer’s Covid-19 antiviral Paxlovid efficacy has been early intervention, but getting it in time has proven to be a challenge. On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

Labelling 111

Labelling Community Pharmacies Medical Records FDA 111

Pharmacy Times

JULY 20, 2022

Analysis shows that the common infection may be a driver of the disease in adults younger than aged 50 years.

132

132

Pharmacy Times

JULY 20, 2022

Dupilumab (Dupixent) is the first medicine to improve signs of eosinophilic esophagitis and support weight gain in children ages 1 to 11, for whom there are no currently approved treatments.

123

123

European Pharmaceutical Review

JULY 20, 2022

Researchers have shown that ratio of nicotinic acid (NA) to nicotinamide (NAM) in cell cultures significantly increases with the presence of live microorganisms within 24 hours, acting as a useful biomarker for the detection of early-stage microbial contamination in cell therapies. Cell therapies are emerging as promising therapeutic modalities across a range of indications, with mesenchymal stromal cells (MSCs) the most clinically studied cell therapy platform worldwide; however, the nutrient r

111

111

Pharmacy Times

JULY 20, 2022

Duo allows independent and simultaneous determination of early-stage infection and those who are recovering or showing signs of a chronic problem.

123

123

pharmaphorum

JULY 20, 2022

Shares in VBL Therapeutics have lost around 78% of their value in pre-market trading after the company reported a phase 3 trial of its lead gene therapy VB-111 for ovarian cancer failed a pivotal trial. In the OVAL study, VB-111 – also known as ofranergene obadenovec or ofra-vec – was unable to show an improvement in progression-free survival (PFS) or overall survival (OS) in patients with platinum-resistant ovarian cancer.

Chemotherapy 98

Chemotherapy Immunization 98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JULY 20, 2022

Treatment with faricimab-svoa (Vabysmo) may improve vision with fewer injections and treatment sessions for patients with wet age-related macular degeneration compared to other treatments.

123

123

pharmaphorum

JULY 20, 2022

Cancer Research UK has expanded an alliance with investment group Deep Science Ventures with a commitment to support the formation up to 10 new oncology startups. London-based DSV has been working since 2019 with the charity’s Cancer Research Horizons unit, an incubator organisation which was set up to nurture new discoveries in academia and help to bring them to patients.

84

84

Pharmacy Times

JULY 20, 2022

Lumryz (FT218) treats cataplexy and excessive daytime sleepiness caused by narcolepsy.

123

123

PharmExec

JULY 20, 2022

A recent analysis of the biotech market shows promising signs.

59

59

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JULY 20, 2022

Pharmacies and pharmacists are increasingly utilized for point-of-care (POC) services, including testing for infections that can be diagnosed via rapid testing.

122

122

Pharmaceutical Technology

JULY 20, 2022

TSB Therapeutics, a joint venture (JV) majority-owned by Brii Biosciences (Brii Bio), has entered a collaboration with China Resources Pharmaceutical Commercial Group (CR Pharma) for the commercialisation of an antibody therapy, amubarvimab/romlusevimab combination, for Covid-19 in China. . Brii Bio developed the combination therapy in partnership with Tsinghua University and the 3rd People’s Hospital of Shenzhen.

Hospitals 59

Hospitals 59

Pharmacy Times

JULY 20, 2022

Hyqvia is an immune globulin with a recombinant human hyaluronidase indicated for the treatment of primary immunodeficiency in adults.

Immunization 73

Immunization 73

Pharmaceutical Technology

JULY 20, 2022

Avista Therapeutics, a University of Pittsburgh Medical Center (UPMC) spinout, has entered a collaboration with Roche for developing new AAV gene therapy vectors for eyes. The alliance plans to leverage the single-cell adeno-associated virus (AAV) engineering (scAAVengr) platform technology of Avista to develop intravitreal AAV capsids for a Roche-defined profile.

59

59

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JULY 20, 2022

Donald Klepser, PhD, MBA, professor and dean of academic affairs at the College of Pharmacy in the University of Nebraska Medical Center, discusses how pharmacy technicians can manage their own stress and burnout.

73

73

DiversifyRx

JULY 20, 2022

Does a world without PBMs seem blissful? . Close your eyes and just imagine what pharmacy would be like without PBMs. Are you joyous about the lack of audits, headaches, clawbacks, and DIR fees? Can you imagine your pharmacy profit soaring without PBMs? This fantasy seems pretty awesome, right? I am sorry to be the bearer of bad news. Even without PBMs, many pharmacy owners would still struggle. .

Independent Pharmacies 52

Independent Pharmacies 52

Pharmacy Times

JULY 20, 2022

Pharmacy’s workers' compensation claims for medication expenses are basis of action.

65

65

Viseven

JULY 20, 2022

Imagine you wake up an omnichannel marketer in the middle of the night and ask: What does omnichannel strategy implementation start with ? We bet you’ll hear segmentation among the mumbled words. . Any decent omnichannel strategy requires proper target audience segmentation, and pharmaceutical marketing is no exception. And here’s the thing. Pharmaceutical marketing is a specific area where an omnichannel marketer cannot simply use best practices from other industries and hope they’ll work

Communication 52

Communication Nursing Homes Hospitals 52

Pharmacy Times

JULY 20, 2022

This inflammation of the colon poses a substantial burden to patients and the health care system.

65

65

Oswald's

JULY 20, 2022

Believe it or not, kids are going back to school in a month! Crazy, right? Even though a month may seem like plenty of time to get your kids what they need, you may want to get things now–while you still have a selection. Popular products and quality brands seem to sell out faster than… The post Get an Early Start on Back to School Shopping! appeared first on Oswald's Pharmacy.

52

52

Pharmacy Times

JULY 20, 2022

At the end of the day, we're interdisciplinary in terms of how it is that we need to manage our patients.

65

65

PharmExec

JULY 20, 2022

Outlook for orphan PRMA environment in the US, EU4, and UK.

52

52

Pharmacy Times

JULY 20, 2022

PSAO supports community pharmacies through patient access by unlocking the right payer agreements.

Independent Pharmacies 65

Independent Pharmacies Community Pharmacies 65

Outsourcing Pharma

JULY 20, 2022

Epistemic AI, Cincinnati Childrenâs Hospital Medical Center, and Boomer Esiason Foundation are working together to advance research into the rare disease.

Hospitals 52

Hospitals 52

Pharmacy Times

JULY 20, 2022

Physician’s Choice Joint Support helps with joint flexibility and repair, as well as a healthy inflammatory response.

65

65

Pharmaceutical Commerce

JULY 20, 2022

Center will feature a $1.4 billion investment plan.

52

52

Pharmacy Times

JULY 20, 2022

Quality refers to a set of systems that minimizes errors, maximizes performance and efficiency, and which provides the user with an optimal experience to receive the greatest health benefits.

65

65

pharmaphorum

JULY 20, 2022

Armed with a $100 million second-round financing, CAMP4 Therapeutics is preparing to start the first clinical trial of a drug targeting regulatory RNA (regRNA) molecules that can be used to fine-tune the expression of genes. The Cambridge, Massachusetts biotech has discovered that areas of the non-coding parts of the human genome – referred to by its chief executive Josh Mandel-Brehm (pictured above) as the “dark side” of the genome – actually produce regRNAs that control the express

Compounding 52

Compounding 52

Pharmaceutical Commerce

JULY 20, 2022

If there’s anything we learned from the pandemic, it’s the critical need to analyze patient outcome data in real time to stay informed on the safety and efficacy of treatments in the real world.

52

52